Detalles de la búsqueda
1.
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model.
Cancer Immunol Immunother
; 72(9): 3003-3012, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37289257
2.
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer.
J Nanobiotechnology
; 20(1): 417, 2022 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36123677
3.
Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers.
Int J Clin Pract
; 2022: 7473649, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35685603
4.
Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma.
Gynecol Oncol
; 161(3): 645-652, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33795130
5.
A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model.
J Nanobiotechnology
; 19(1): 416, 2021 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34895262
6.
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy.
J Exp Clin Cancer Res
; 43(1): 70, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443968
7.
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model.
Res Sq
; 2023 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36824846
8.
Radiation Therapy Modulates Tumor Physical Characteristics to Reduce Intratumoral Pressure and Enhance Intratumoral Drug Delivery and Retention.
Adv Radiat Oncol
; 8(2): 101137, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632088
9.
Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease.
Radiother Oncol
; 183: 109618, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921766
10.
Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung Cancer.
Cancer Immunol Res
; 11(4): 486-500, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36700864
11.
High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses.
Cancers (Basel)
; 14(1)2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008385
12.
Pulsed radiotherapy to mitigate high tumor burden and generate immune memory.
Front Immunol
; 13: 984318, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36275767
13.
The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy.
J Inflamm Res
; 14: 4433-4444, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34511977
14.
Double isocenter optimization with HD-MLC linear accelerator to treat extended fields in patients with head and neck cancers.
J BUON
; 26(4): 1571-1581, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34565021
15.
Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer.
Front Oncol
; 11: 737425, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34497773
16.
Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis.
J Oncol
; 2021: 6688138, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33552158
17.
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity.
Transl Oncol
; 14(2): 100983, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33340886
18.
Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease.
Semin Radiat Oncol
; 31(3): 217-226, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34090648
19.
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial.
Radiother Oncol
; 162: 60-67, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237343
20.
Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy.
Gastroenterol Res Pract
; 2020: 5701949, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32802045